IMCB PJSC Logo

IMCB PJSC

Personal biobank preserving umbilical cord stem cells for families' future therapeutic use.

GEMA | MOEX

Overview

Corporate Details

ISIN(s):
RU000A100GC7
LEI:
Country:
Russian Federation
Address:
Gubkina St. House 3, 11933 Moscow
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IMCB PJSC is a biotechnology company and a leading personal stem cell biobank, operating under the Gemabank brand. The company specializes in the processing and long-term cryopreservation of hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue. These services provide families with a personalized biological resource for potential use in cell therapy to treat a wide range of hematological, immune, and genetic disorders. Established in 2003, the company manages tens of thousands of client biomaterial samples and has a documented history of successfully providing them for clinical applications. IMCB is also engaged in research and development of innovative gene therapy and biopharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IMCB PJSC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMCB PJSC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMCB PJSC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ceres Power Holdings PLC Logo
Licensing solid oxide tech (SOFC/SOEC) for clean power and green hydrogen to global partners.
United Kingdom
CWR
Certara, Inc. Logo
Accelerating new medicines with biosimulation software and services for pharma & biotech.
United States of America
CERT
CervoMed Inc. Logo
Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.
United States of America
CRVO
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea
085660
CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America
CRL
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan
4583
Chordate Medical Holding AB Logo
Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.
Sweden
CMH
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan
190A
Cibus, Inc. Logo
Develops & licenses gene-edited, non-transgenic traits to the seed industry for resilient crops.
United States of America
CBUS

Talk to a Data Expert

Have a question? We'll get back to you promptly.